J.M. Jurado

4.3k total citations
72 papers, 3.4k citations indexed

About

J.M. Jurado is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, J.M. Jurado has authored 72 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in J.M. Jurado's work include Cancer Genomics and Diagnostics (12 papers), Genetic factors in colorectal cancer (10 papers) and BRCA gene mutations in cancer (9 papers). J.M. Jurado is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Genetic factors in colorectal cancer (10 papers) and BRCA gene mutations in cancer (9 papers). J.M. Jurado collaborates with scholars based in Spain, Colombia and United Kingdom. J.M. Jurado's co-authors include Mariano Provencio, Félix Bonilla, Gemma Domínguez, Pilar España, F. Bonilla, Cristina Peña, Javier Silva, José M. Silva, Alberto Múñoz and Rufo Rodríguez and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

J.M. Jurado

70 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Jurado Spain 33 2.3k 1.4k 893 495 386 72 3.4k
Qingyun Liu China 18 2.1k 0.9× 996 0.7× 1.7k 2.0× 333 0.7× 311 0.8× 31 3.4k
Dieter Niederacher Germany 38 2.4k 1.0× 1.4k 1.0× 1.6k 1.8× 432 0.9× 854 2.2× 143 4.2k
Nicolaus Friedrichs Germany 30 1.7k 0.7× 595 0.4× 945 1.1× 936 1.9× 403 1.0× 75 3.3k
Elizabeth Vincan Australia 25 2.5k 1.1× 1.2k 0.9× 952 1.1× 262 0.5× 261 0.7× 60 3.4k
Rainer Engers Germany 30 1.6k 0.7× 622 0.4× 842 0.9× 321 0.6× 258 0.7× 67 2.8k
Cornelisse Cj Netherlands 24 1.4k 0.6× 689 0.5× 1.0k 1.1× 445 0.9× 713 1.8× 48 2.9k
Tsun Leung Chan Hong Kong 22 2.5k 1.1× 2.0k 1.4× 1.5k 1.7× 1.4k 2.9× 510 1.3× 42 4.2k
María Aparecida Nagai Brazil 27 1.6k 0.7× 417 0.3× 619 0.7× 301 0.6× 261 0.7× 113 2.5k
Yvonne Tsai United States 26 2.8k 1.2× 935 0.7× 1.0k 1.2× 568 1.1× 431 1.1× 34 4.2k

Countries citing papers authored by J.M. Jurado

Since Specialization
Citations

This map shows the geographic impact of J.M. Jurado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Jurado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Jurado more than expected).

Fields of papers citing papers by J.M. Jurado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Jurado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Jurado. The network helps show where J.M. Jurado may publish in the future.

Co-authorship network of co-authors of J.M. Jurado

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Jurado. A scholar is included among the top collaborators of J.M. Jurado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Jurado. J.M. Jurado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurado, J.M., et al.. (2020). Reconstrucción del tránsito intestinal en paciente con nivolumab y rectitis de exclusión. Gastroenterología y Hepatología. 45. 9–10.
2.
Blancas, Isabel, Isabel Ruiz‐Ávila, J.M. Jurado, et al.. (2020). Immunophenotypic Conversion between Primary and Relapse Breast Cancer and its Effects on Survival. Gynecologic and Obstetric Investigation. 85(3). 259–266. 4 indexed citations
3.
4.
Guijarro-Muñoz, Irene, Esther Martínez-Martínez, J.M. Jurado, et al.. (2013). Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab. Medical Oncology. 30(2). 572–572. 22 indexed citations
5.
Jurado, J.M., et al.. (2012). Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report. Journal of Medical Case Reports. 6(1). 424–424. 1 indexed citations
6.
Rodríguez, María E., Marta Compte, Elisa Cisneros, et al.. (2011). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes and Cancer. 51(4). 409–418. 249 indexed citations
7.
Mohammed, N., María E. Rodríguez, J.M. Jurado, et al.. (2011). EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages. Oncology Letters. 2(4). 719–724. 23 indexed citations
8.
Gómez, Irene, Cristina Peña, Concepción Muñoz, et al.. (2011). TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival. PLoS ONE. 6(3). e18023–e18023. 60 indexed citations
9.
Barbáchano, Antonio, Paloma Ordóñez‐Morán, J.M. Jurado, et al.. (2010). SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene. 29(34). 4800–4813. 60 indexed citations
10.
Zaballos, Ángel, Mariano Provencio, Luís Lombardía, et al.. (2010). Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. European Respiratory Journal. 37(3). 617–623. 228 indexed citations
11.
Peña, Cristina, J.M. Jurado, Vanesa García‐Barberán, et al.. (2006). Regulation of E-cadherin and vitamin D receptor by SNAIL and ZEB1 in colon cancer. Cancer Research. 66. 28–28. 1 indexed citations
12.
Jurado, J.M., et al.. (2003). Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut. 52(12). 1756–1763. 21 indexed citations
13.
Domínguez, Gemma, Javier Silva, J.M. Jurado, et al.. (2003). Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 530(1-2). 9–17. 71 indexed citations
14.
Silva, José M., Gemma Domínguez, J.M. Jurado, et al.. (2003). Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. The Journal of Pathology. 199(3). 289–297. 90 indexed citations
15.
González‐Pérez, Ruperto, Antonio Sánchez, Gemma Domínguez, et al.. (2000). Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance. Annals of Oncology. 11(9). 1097–1104. 80 indexed citations
16.
Domínguez, Gemma, María Jesús García Villanueva, Ruperto González‐Pérez, et al.. (1999). Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. British Journal of Cancer. 80(8). 1262–1264. 109 indexed citations
17.
González‐Pérez, Ruperto, Gemma Domínguez, J.M. Jurado, et al.. (1999). Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. British Journal of Cancer. 81(3). 503–509. 61 indexed citations
18.
Jurado, J.M., R Martinez Gonzalez, Gemma Domínguez, et al.. (1999). Abnormal frequencies of alleles in polymorphic markers of the 17q21 region is associated with breast cancer. Cancer Letters. 138(1-2). 209–215. 3 indexed citations
19.
Silva, José M., R Martinez Gonzalez, Mariano Provencio, et al.. (1999). Loss of heterozygosity in BRCA1 and BRCA2 markers and high‐grade malignancy in breast cancer. Breast Cancer Research and Treatment. 53(1). 9–17. 32 indexed citations
20.
Provencio, Mariano, et al.. (1998). Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations.. Journal of Clinical Oncology. 16(1). 115–120. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingyun Liu Breakdown of academic impact, for papers by Dieter Niederacher Breakdown of academic impact, for papers by Nicolaus Friedrichs Breakdown of academic impact, for papers by Elizabeth Vincan Breakdown of academic impact, for papers by Rainer Engers Breakdown of academic impact, for papers by Cornelisse Cj Breakdown of academic impact, for papers by Tsun Leung Chan Breakdown of academic impact, for papers by María Aparecida Nagai Breakdown of academic impact, for papers by Yvonne Tsai
Rankless by CCL
2026